Michael Nicholson
President at Inceptor Bio LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy R. Kasmoch | M | 62 | 18 years | |
| Shailesh Maingi | M | - |
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | 4 years |
| Mark D. Hagans | M | 57 | 18 years | |
| Brent Stead | M | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
| Steven Kanner | M | 65 |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | 1 years |
| George Fotiades | M | 70 |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| Frank Lis | M | - |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | 3 years |
| Odisho Israel | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
| Abe Maingi | M | - |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| David Johnston | M | - |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| Adam Kaplin | M | 57 |
The Johns Hopkins University
| 22 years |
| Abraham Surinder Maingi | M | - |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| Nikhil Thatte | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
| Tirtha Chakraborty | M | 51 |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | 1 years |
| Derek Hennecke | M | - |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| Elizabeth Smith | F | - |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| Mark Gilbert | M | 63 |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | 2 years |
| Matthias Schroff | M | 56 |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | 1 years |
| Matthias Stuber | M | - |
The Johns Hopkins University
| 22 years |
| Mark R. Bamforth | M | 61 |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | - |
| Daniel Hetu | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
| Frederic Auger | M | - |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James H. Hartung | M | 81 | 9 years | |
| Nikhil S. Palekar | M | - |
The Johns Hopkins University
| 5 years |
| Sam Yilmaz | M | - |
The Johns Hopkins University
| 7 years |
| Kimberly Lyons | F | - |
The State University of New York
| 6 years |
| Joseph H. Scheib | M | 67 | 11 years | |
| Sean P. McWilliams | M | - |
The Johns Hopkins University
| 9 years |
| Omar Shaher Itum | M | - |
The Johns Hopkins University
| 5 years |
| Philip James Aiken | M | - |
The Johns Hopkins University
| 4 years |
| Francisco Tejada | M | - |
The Johns Hopkins University
| 8 years |
| James A. Tzitzouris | M | 50 |
The Johns Hopkins University
| 6 years |
| Shahab Vagefi | M | - |
The Johns Hopkins University
| 5 years |
| Nasif Mohammed | M | - |
The Johns Hopkins University
| 5 years |
| Ajay Mantha | M | - |
The Johns Hopkins University
| 4 years |
| Mark Thomas Kelly | M | - |
The Johns Hopkins University
| 6 years |
| Jeff Raider | M | 43 |
The Johns Hopkins University
| 5 years |
| Thomas L. Kovacik | M | 76 | 9 years | |
| Carl Richard | M | 97 | 11 years | |
| Jan Martin Witte | M | 50 |
The Johns Hopkins University
| 6 years |
| Weina Shi | F | - |
The Johns Hopkins University
| 5 years |
| Peter Donnelly | M | - |
The Johns Hopkins University
| 3 years |
| Zhi Hua Xiao | M | 50 |
The State University of New York
| 7 years |
| James Gettinger | M | - |
The Johns Hopkins University
| 4 years |
| Stephanie Komsa | F | - |
The Johns Hopkins University
| 2 years |
| Suzanne Angell | F | - |
The Johns Hopkins University
| 3 years |
| Katie Chekan | F | - |
The Johns Hopkins University
| 4 years |
| Janet U. Jones | F | - |
The Johns Hopkins University
| 4 years |
| Kate Kelberg | F | - |
The Johns Hopkins University
| 4 years |
| NEIL P KEEGAN | M | - |
The Johns Hopkins University
| 2 years |
| Mark Goldberg | M | - |
The Johns Hopkins University
| 4 years |
| Gregory Matthew Saiontz | M | - |
The Johns Hopkins University
| 2 years |
| Jessica Kenley | F | - |
The Johns Hopkins University
| 4 years |
| Obdulio Piloto | M | - |
The Johns Hopkins University
| 3 years |
| Yu Chen Jiao | M | 47 |
The Johns Hopkins University
| 3 years |
| Albert Gerard Koenders | M | 66 |
The Johns Hopkins University
| 2 years |
| Melissa Odorzynski | M | - |
The Johns Hopkins University
| 2 years |
| Shefali Agarwal | M | 50 |
The Johns Hopkins University
| 3 years |
| Dilveer Vahali | M | - |
The Johns Hopkins University
| 4 years |
| Chadi Farhat | M | 48 |
The Johns Hopkins University
| 2 years |
| Chuck Crow | M | - |
The Johns Hopkins University
| 10 years |
| Neel Tiku | M | - |
The Johns Hopkins University
| 3 years |
| Brigid O'Brien | F | - |
The Johns Hopkins University
| 7 years |
| Aron Betru | M | - |
The Johns Hopkins University
| 3 years |
| Gordon Holt | M | - |
The Johns Hopkins University
| 4 years |
| Benjamin McAbee | M | - |
The Johns Hopkins University
| 4 years |
| Gwendolyn Binder-Scholl | M | 49 |
The Johns Hopkins University
| 3 years |
| John Philip Kostuik | M | 86 |
The Johns Hopkins University
| 12 years |
| Jamie Terranova | M | - |
The Johns Hopkins University
| 4 years |
| Daniel G. Alfred | M | - |
The Johns Hopkins University
| 4 years |
| Tim P. VandenBerg | M | - |
The Johns Hopkins University
| 5 years |
| David Hirsch | M | 53 |
The Johns Hopkins University
| 13 years |
| Anne-Sybil Bragadir | F | - |
The Johns Hopkins University
| 4 years |
| David Eisner | M | - |
The Johns Hopkins University
| 1 years |
| John Fallon | M | 76 |
The State University of New York
| 4 years |
| Jonathan Ho | M | - |
The Johns Hopkins University
| 3 years |
| Hyam Levitsky | M | 66 |
The Johns Hopkins University
| 6 years |
| David Kim | M | - |
The Johns Hopkins University
| 5 years |
| Daniel Kim | M | - |
The Johns Hopkins University
| 3 years |
| Jillian Miller | F | - |
The Johns Hopkins University
| 4 years |
| Heinz Joachim List | M | - |
The Johns Hopkins University
| 2 years |
| Thomas Banks | M | - |
The Johns Hopkins University
| 4 years |
| Jonathan Kahnowitz | M | - |
The Johns Hopkins University
| 4 years |
| Ryan Kealy | M | - |
The Johns Hopkins University
| 4 years |
| Rachel Lopes | F | - |
The Johns Hopkins University
| 4 years |
| Ryan Lanpher | M | 39 |
The Johns Hopkins University
| 4 years |
| Mark Schoenberg | M | 66 |
The Johns Hopkins University
| 9 years |
| Andreas Schobel | M | - |
The Johns Hopkins University
| 4 years |
| Lucy Webster | F | - |
The Johns Hopkins University
| 4 years |
| Sean Pattap | M | - |
The Johns Hopkins University
| 4 years |
| Christopher Muirhead | M | 43 |
The Johns Hopkins University
| 2 years |
| Stuart Harshbarger | M | - |
The Johns Hopkins University
| 4 years |
| Steven Shui | M | - |
The Johns Hopkins University
| 4 years |
| John J. Kernan | M | - |
The Johns Hopkins University
| 4 years |
| Rocco Francica | M | - |
The Johns Hopkins University
| 4 years |
| John Criezis | M | - |
The Johns Hopkins University
| 4 years |
| Jerry Xuan Chen | F | - |
The Johns Hopkins University
| 4 years |
| Mark D. Geller | M | - |
The Johns Hopkins University
| 1 years |
| Yong Kwon | M | - |
The Johns Hopkins University
| 4 years |
| Hyun-Mi Yang | M | 61 |
The State University of New York
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| Canada | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Nicholson
- Personal Network
